|
gptkbp:instanceOf
|
gptkb:biotechnology
gptkb:subsidiary
|
|
gptkbp:CEO
|
gptkb:Stephen_Gillett
|
|
gptkbp:collaboratedWith
|
gptkb:ResMed
gptkb:Pfizer
gptkb:Johnson_&_Johnson
gptkb:Sanofi
gptkb:Novartis
gptkb:Dexcom
gptkb:iRhythm
GlaxoSmithKline
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:focusesOn
|
medical devices
clinical research
disease prevention
life sciences research
health data analysis
|
|
gptkbp:formerName
|
gptkb:Google_Life_Sciences
|
|
gptkbp:founded
|
2015
|
|
gptkbp:fundingRound
|
$1 billion (2019)
$1 billion (2022)
$700 million (2020)
|
|
gptkbp:headquartersLocation
|
gptkb:South_San_Francisco,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Verily Life Sciences
|
|
gptkbp:industry
|
gptkb:biotechnology
healthcare
|
|
gptkbp:keyPerson
|
gptkb:Andy_Conrad
gptkb:Brian_Otis
gptkb:Jessica_Mega
gptkb:Stephen_Gillett
|
|
gptkbp:logo
|
Verily Life Sciences logo.svg
|
|
gptkbp:mission
|
to make health data useful so people enjoy healthier lives
|
|
gptkbp:notableProject
|
gptkb:Onduo
gptkb:Project_Baseline
smart contact lens
COVID-19 screening tool
|
|
gptkbp:numberOfEmployees
|
over 1,000 (as of 2023)
|
|
gptkbp:parentCompany
|
gptkb:Alphabet_Inc.
|
|
gptkbp:product
|
gptkb:Onduo_virtual_diabetes_clinic
gptkb:Verily_Baseline_Platform
gptkb:Verily_COVID-19_testing_platform
gptkb:Verily_Study_Watch
smart contact lens (project discontinued)
|
|
gptkbp:socialMedia
|
https://www.linkedin.com/company/verily-life-sciences/
|
|
gptkbp:spinOff
|
gptkb:Google_X
|
|
gptkbp:twitter
|
@verilylifesci
|
|
gptkbp:type
|
private
|
|
gptkbp:website
|
https://verily.com/
|
|
gptkbp:bfsParent
|
gptkb:Andrew_Conrad
gptkb:Vivian_S._Lee
gptkb:Nancy_Dougherty
|
|
gptkbp:bfsLayer
|
6
|